Summary
Graph AI, a tech startup specializing in the pharmaceutical industry, has secured $13.3 million in Series A funding led by Insight Partners, with participation from Bessemer Venture Partners. The company plans to use the capital to expand its presence in the US and Europe and accelerate product development for its AI platform, which automates pharmacovigilance and patient safety processes.